Skip to main content
Autobound logo

AstraZeneca news and events in 2026

AstraZeneca news, hiring, acquisitions and Reddit, Glassdoor, podcast and web signals in one place. Every row is dated and links to its source.

PublicConsumer Services10,000+ employeesastrazeneca.comLinkedIn

Dated updates
71
Last event
Sep 29, 2026
Open rolesSnapshot Sep 29, 2026
453

Overview

AstraZeneca by topic

Latest events

Latest AstraZeneca events

All AstraZeneca news →
  1. Partnership
    AstraZeneca invests $2 billion in Summit Therapeutics in cancer drug dealWith Summit Therapeutics Inc.
    proactiveinvestors.com
  2. In development
    UK Retail Sales Rebound; Softcat Finalizes FundraisingWith Alexion
    ch.zonebourse.com
  3. Investment
    Multiply Labs Raises $75M in Series B Funding to Scale Robotic Drug ManufacturingAstraZeneca Ventures participated in Multiply Labs' $75 million Series B funding round.
    theaiinsider.tech
  4. Investment
    AstraZeneca shares oversold after trial flops and merger talk, says UBSAstraZeneca has recently invested $15 billion in China to support its ambition of reaching $80 billion in revenue.
    proactiveinvestors.com
  5. In development
    New drug shows promise in reducing COPD symptoms in former and current smokers, clinical trials show - ABC News - Breaking News, Latest News and VideosAstraZeneca is developing tozorakimab, a first-in-class monoclonal antibody, which has shown promise in late-stage clinical trials for reducing COPD symptoms in smokers and former smokers.
    abcnews.com
  6. In development
    Assessment of the Rheumatoid Arthritis Market 2026-2036 Featuring Rise Therapeutics, Taiho Pharmaceutical, Abbvie, Eli Lilly/Incyte, and AstraZenecaAstraZeneca is developing AZD1163, a rheumatoid arthritis drug candidate which has advanced to Phase II clinical trials.
    globenewswire.com
  7. In development
    AstraZeneca Secures FDA Nod for New Breast Cancer Therapy EtcamahAstraZeneca is evaluating its breast cancer drug Etcamah in several phase III studies (SERENA-4, CAMBRIA-1, CAMBRIA-2) to potentially expand its use as both a monotherapy and in combination treatments.
    theglobeandmail.com
  8. Launch
    AstraZeneca’s Breast Cancer Drug Etcamah Gets US FDA ApprovalAstraZeneca received FDA approval for its breast cancer drug, camizestrant, which will be marketed under the brand name Etcamah.
    freepressjournal.in
  9. In development
    C4X Discovery to receive milestone payment for NRF2 exclusive worldwide license agreementAstraZeneca is advancing AZD4916, an oral NRF2 activator licensed from C4X Discovery, into a Phase I study for the treatment of inflammatory and respiratory diseases.
    globenewswire.com
  10. Launch
    EU approves Enhertu-pertuzumab combo for first-line HER2-positive breast cancerWith Daiichi Sankyo
    thepharmaletter.com

Showing 10 of 25 events. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track AstraZeneca with the Signal API

One POST /v1/companies/enrich call with astrazeneca.com returns every signal type for AstraZeneca, each with its source. Or ask Claude through MCP.

Start Free1,000 free creditsUse it in Claude via MCP

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"astrazeneca.com","limit":20}'

Same industry

Companies related to AstraZeneca

AstraZeneca questions

What is the latest news on AstraZeneca?
On Sep 29, 2026, proactiveinvestors.com reported: AstraZeneca invests $2 billion in Summit Therapeutics in cancer drug deal. This page tracks 25 news events for AstraZeneca since Jul 22, 2026, each with a date and a source link.
What is going on with AstraZeneca?
In the 90 days to Sep 30, 2026, Autobound tracked 25 news events, 4 hiring snapshots, 1 deal, 26 signals for AstraZeneca. The newest story is from Sep 29, 2026 (Partnership), reported by proactiveinvestors.com.
Has AstraZeneca announced any acquisitions?
The latest deal story is from Aug 5, 2026. pymnts.com reported: CPI | AstraZeneca, Bristol Myers Dismiss Merger Talk Speculation. The acquisitions page lists 1 deal with a source for each.
What else does Autobound track for AstraZeneca?
Beyond news and filings, Autobound lists 46+ signals for AstraZeneca from 6 sources: Website changes (15+), X (Twitter) (10), Patents (10), LinkedIn (7), Podcasts (2), Conference talks (2). See the AstraZeneca signals page for the dated list.
Is AstraZeneca hiring right now?
Yes. As of Sep 29, 2026, AstraZeneca had 453 open roles, and Sales had the most with 32.

Source. News, SEC filings (8-K, 10-K, 10-Q, Form D), hiring data and other signals (Reddit, podcasts, Glassdoor, reviews, social posts, patents, web traffic) from the Autobound Signal API.

Method. Stories are grouped when they report the same event within 14 days. Rows that do not name the company are removed. Each row links its source.

Data as of .

How this data is built →Get it from the Signal API →